☰

Gregory P. Levin, Ph.D. - Publications

Affiliations: 
2012 Biostatistics - Public Health University of Washington, Seattle, Seattle, WA 
Area:
Biostatistics Biology
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Levin GP, Emerson SC, Emerson SS. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size. Biometrics. 70: 556-67. PMID 24766094 DOI: 10.1111/Biom.12168  0.603
2013 Sachs MC, Shoben A, Levin GP, Robinson-Cohen C, Hoofnagle AN, Swords-Jenny N, Ix JH, Budoff M, Lutsey PL, Siscovick DS, Kestenbaum B, de Boer IH. Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis. The American Journal of Clinical Nutrition. 97: 1243-51. PMID 23615830 DOI: 10.3945/Ajcn.112.054502  0.579
2013 Levin GP, Kestenbaum B. Genetic variants modifying the influence of vitamin D--reply. Jama. 309: 873. PMID 23462777 DOI: 10.1001/Jama.2013.638  0.313
2013 Levin GP, Emerson SC, Emerson SS. Adaptive clinical trial designs with pre-specified rules for modifying the sample size: understanding efficient types of adaptation. Statistics in Medicine. 32: 1259-75; discussion . PMID 23081665 DOI: 10.1002/Sim.5662  0.603
2013 Levin GP, Emerson SC, Emerson SS. Authors' response to 'Adaptive clinical trial designs with pre-specified rules formodifying the sample size: Adifferentperspective' Statistics in Medicine. 32: 1280-1282. DOI: 10.1002/Sim.5749  0.595
2012 Levin GP, Robinson-Cohen C, de Boer IH, Houston DK, Lohman K, Liu Y, Kritchevsky SB, Cauley JA, Tanaka T, Ferrucci L, Bandinelli S, Patel KV, Hagström E, Michaëlsson K, Melhus H, et al. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. Jama. 308: 1898-905. PMID 23150009 DOI: 10.1001/Jama.2012.17304  0.4
2012 Bosworth CR, Levin G, Robinson-Cohen C, Hoofnagle AN, Ruzinski J, Young B, Schwartz SM, Himmelfarb J, Kestenbaum B, de Boer IH. The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease. Kidney International. 82: 693-700. PMID 22648296 DOI: 10.1038/Ki.2012.193  0.411
2012 de Boer IH, Levin G, Robinson-Cohen C, Biggs ML, Hoofnagle AN, Siscovick DS, Kestenbaum B. Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study. Annals of Internal Medicine. 156: 627-34. PMID 22547472 DOI: 10.7326/0003-4819-156-9-201205010-00004  0.429
2012 Shoben AB, Levin G, de Boer IH, Yeung C, Watnick S, Ayers E, Kestenbaum B. Variation in oral calcitriol response in patients with stages 3-4 CKD. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 59: 645-52. PMID 22285224 DOI: 10.1053/J.Ajkd.2011.11.041  0.522
2011 Shoben AB, Kestenbaum B, Levin G, Hoofnagle AN, Psaty BM, Siscovick DS, de Boer IH. Seasonal variation in 25-hydroxyvitamin D concentrations in the cardiovascular health study. American Journal of Epidemiology. 174: 1363-72. PMID 22112344 DOI: 10.1093/Aje/Kwr258  0.576
2011 Emerson SS, Levin GP, Emerson SC. Comments on 'Adaptive increase in sample size when interim results are promising: a practical guide with examples'. Statistics in Medicine. 30: 3285-301; discussion. PMID 22105691 DOI: 10.1002/Sim.4271  0.595
Show low-probability matches.